Aehr Test Systems filings document material events, operating results, capital actions and governance matters for a semiconductor test and burn-in equipment company. Recent Form 8-K disclosures include quarterly financial-result releases covering revenue, bookings, backlog, cash position and GAAP and non-GAAP earnings measures.
The filing record also includes capital-structure disclosures tied to an at-the-market common stock offering under a Form S-3 registration statement, along with proxy and annual meeting materials. Those governance filings address director elections, shareholder voting results, amendments to the company’s equity incentive and employee stock purchase plans, auditor ratification and executive-compensation matters.
Aehr Test Systems (AEHR) Form 144 notice reports a proposed sale of 10,000 common shares, with an aggregate market value of $201,600, to be sold through Charles Schwab & Co., Inc. on or about 08/15/2025 on Nasdaq. The shares were acquired on 04/05/2023 via stock option exercise from the issuer and were paid for in cash on the acquisition date. The filer reports no securities sold in the past three months and includes the standard representation that they are not aware of undisclosed material adverse information about the issuer. The filing presents a routine insider sale notification rather than operational or financial results.
AEHR Test Systems (AEHR) filed a Form 4 for EVP Alberto Salamone. On 08/01/2025, 186 common shares were withheld (code “F”) at $16.84 each—about $3.1 k—to cover taxes due on the vesting of restricted stock units. Such F-code transactions are executed by the company and are not open-market sales, so they do not reflect discretionary selling by the insider.
Following the withholding, Salamone directly owns 78,349 shares, which still include unvested RSUs; no derivative securities were reported. The change is immaterial to both his ownership percentage and the company’s share count. The filing is therefore routine and has neutral investment impact.